+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Preeclampsia Laboratory Testing Market 2023-2027

  • PDF Icon

    Report

  • 162 Pages
  • March 2023
  • Region: Global
  • TechNavio
  • ID: 5750593
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The preeclampsia laboratory testing market is forecast to grow by $785.73 million during 2022-2027, accelerating at a CAGR of 8% during the forecast period. The report on the preeclampsia laboratory testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by market expansion in emerging economies, increasing incidence of preterm births, and rising number of gynecology clinics.

The preeclampsia laboratory testing market is segmented as below:

By Product Type

  • Consumables
  • Instruments

By Test

  • Blood test
  • Urine test
  • Others

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing need for companion diagnostics as one of the prime reasons driving the preeclampsia laboratory testing market growth during the next few years. Also, growing awareness of mother and fetal screening and monitoring procedures and implementation of organic and inorganic strategies by market players will lead to sizable demand in the market.

The report on the preeclampsia laboratory testing market covers the following areas:

  • Preeclampsia laboratory testing market sizing
  • Preeclampsia laboratory testing market forecast
  • Preeclampsia laboratory testing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading preeclampsia laboratory testing market vendors that include Abbott Laboratories, ACON Laboratories Inc., Bio Rad Laboratories Inc., BioCheck Inc., bioMerieux SA, Biora Therapeutics Inc., Cardinal Health Inc., Diabetomics Inc., F. Hoffmann La Roche Ltd., GestVision Inc., Lifeassay Diagnostics Pty Ltd., MedGyn Products Inc., Metabolomic Diagnostics, MOMM Diagnostics, Perkin Elmer Inc., Quidel Corp., Sera Prognostics Inc., Siemens AG, Thermo Fisher Scientific Inc., and Avecon Healthcare Pvt. Ltd. Also, the preeclampsia laboratory testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Test
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global preeclampsia laboratory testing market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global preeclampsia laboratory testing market 2017 - 2021 ($ million)
4.2 Product Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Type Segment 2017 - 2021 ($ million)
4.3 Test Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Test Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product Type
6.1 Market segments
Exhibit 30: Chart on Product Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product Type - Market share 2022-2027 (%)
6.2 Comparison by Product Type
Exhibit 32: Chart on Comparison by Product Type
Exhibit 33: Data Table on Comparison by Product Type
6.3 Consumables - Market size and forecast 2022-2027
Exhibit 34: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Consumables - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
6.4 Instruments - Market size and forecast 2022-2027
Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product Type
Exhibit 42: Market opportunity by Product Type ($ million)
Exhibit 43: Data Table on Market opportunity by Product Type ($ million)

7 Market Segmentation by Test
7.1 Market segments
Exhibit 44: Chart on Test - Market share 2022-2027 (%)
Exhibit 45: Data Table on Test - Market share 2022-2027 (%)
7.2 Comparison by Test
Exhibit 46: Chart on Comparison by Test
Exhibit 47: Data Table on Comparison by Test
7.3 Blood test - Market size and forecast 2022-2027
Exhibit 48: Chart on Blood test - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Blood test - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Blood test - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Blood test - Year-over-year growth 2022-2027 (%)
7.4 Urine test - Market size and forecast 2022-2027
Exhibit 52: Chart on Urine test - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Urine test - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Urine test - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Urine test - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
Exhibit 56: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Test
Exhibit 60: Market opportunity by Test ($ million)
Exhibit 61: Data Table on Market opportunity by Test ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share by geography 2022-2027 (%)
Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 India - Market size and forecast 2022-2027
Exhibit 99: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on India - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 103: Market opportunity by geography ($ million)
Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 111: Abbott Laboratories - Overview
Exhibit 112: Abbott Laboratories - Business segments
Exhibit 113: Abbott Laboratories - Key news
Exhibit 114: Abbott Laboratories - Key offerings
Exhibit 115: Abbott Laboratories - Segment focus
12.4 ACON Laboratories Inc.
Exhibit 116: ACON Laboratories Inc. - Overview
Exhibit 117: ACON Laboratories Inc. - Product/Service
Exhibit 118: ACON Laboratories Inc. - Key offerings
12.5 Bio Rad Laboratories Inc.
Exhibit 119: Bio Rad Laboratories Inc. - Overview
Exhibit 120: Bio Rad Laboratories Inc. - Business segments
Exhibit 121: Bio Rad Laboratories Inc. - Key news
Exhibit 122: Bio Rad Laboratories Inc. - Key offerings
Exhibit 123: Bio Rad Laboratories Inc. - Segment focus
12.6 BioCheck Inc.
Exhibit 124: BioCheck Inc. - Overview
Exhibit 125: BioCheck Inc. - Product/Service
Exhibit 126: BioCheck Inc. - Key offerings
12.7 bioMerieux SA
Exhibit 127: bioMerieux SA - Overview
Exhibit 128: bioMerieux SA - Product/Service
Exhibit 129: bioMerieux SA - Key offerings
12.8 Biora Therapeutics Inc.
Exhibit 130: Biora Therapeutics Inc. - Overview
Exhibit 131: Biora Therapeutics Inc. - Product/Service
Exhibit 132: Biora Therapeutics Inc. - Key offerings
12.9 Cardinal Health Inc.
Exhibit 133: Cardinal Health Inc. - Overview
Exhibit 134: Cardinal Health Inc. - Business segments
Exhibit 135: Cardinal Health Inc. - Key news
Exhibit 136: Cardinal Health Inc. - Key offerings
Exhibit 137: Cardinal Health Inc. - Segment focus
12.10 Diabetomics Inc.
Exhibit 138: Diabetomics Inc. - Overview
Exhibit 139: Diabetomics Inc. - Product/Service
Exhibit 140: Diabetomics Inc. - Key offerings
12.11 F. Hoffmann La Roche Ltd.
Exhibit 141: F. Hoffmann La Roche Ltd. - Overview
Exhibit 142: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 143: F. Hoffmann La Roche Ltd. - Key news
Exhibit 144: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 145: F. Hoffmann La Roche Ltd. - Segment focus
12.12 MedGyn Products Inc.
Exhibit 146: MedGyn Products Inc. - Overview
Exhibit 147: MedGyn Products Inc. - Product/Service
Exhibit 148: MedGyn Products Inc. - Key offerings
12.13 Metabolomic Diagnostics
Exhibit 149: Metabolomic Diagnostics - Overview
Exhibit 150: Metabolomic Diagnostics - Product/Service
Exhibit 151: Metabolomic Diagnostics - Key offerings
12.14 Perkin Elmer Inc.
Exhibit 152: Perkin Elmer Inc. - Overview
Exhibit 153: Perkin Elmer Inc. - Business segments
Exhibit 154: Perkin Elmer Inc. - Key news
Exhibit 155: Perkin Elmer Inc. - Key offerings
Exhibit 156: Perkin Elmer Inc. - Segment focus
12.15 Sera Prognostics Inc.
Exhibit 157: Sera Prognostics Inc. - Overview
Exhibit 158: Sera Prognostics Inc. - Product/Service
Exhibit 159: Sera Prognostics Inc. - Key offerings
12.16 Siemens AG
Exhibit 160: Siemens AG - Overview
Exhibit 161: Siemens AG - Business segments
Exhibit 162: Siemens AG - Key news
Exhibit 163: Siemens AG - Key offerings
Exhibit 164: Siemens AG - Segment focus
12.17 Thermo Fisher Scientific Inc.
Exhibit 165: Thermo Fisher Scientific Inc. - Overview
Exhibit 166: Thermo Fisher Scientific Inc. - Business segments
Exhibit 167: Thermo Fisher Scientific Inc. - Key news
Exhibit 168: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 169: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 170: Inclusions checklist
Exhibit 171: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 172: Currency conversion rates for US$
13.4 Research methodology
Exhibit 173: Research methodology
Exhibit 174: Validation techniques employed for market sizing
Exhibit 175: Information sources
13.5 List of abbreviations
Exhibit 176: List of abbreviations

List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Test
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global preeclampsia laboratory testing market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Product Type Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Test Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Product Type - Market share 2022-2027 (%)
Exhibits 31: Data Table on Product Type - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Product Type
Exhibits 33: Data Table on Comparison by Product Type
Exhibits 34: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Consumables - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Product Type ($ million)
Exhibits 43: Data Table on Market opportunity by Product Type ($ million)
Exhibits 44: Chart on Test - Market share 2022-2027 (%)
Exhibits 45: Data Table on Test - Market share 2022-2027 (%)
Exhibits 46: Chart on Comparison by Test
Exhibits 47: Data Table on Comparison by Test
Exhibits 48: Chart on Blood test - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Data Table on Blood test - Market size and forecast 2022-2027 ($ million)
Exhibits 50: Chart on Blood test - Year-over-year growth 2022-2027 (%)
Exhibits 51: Data Table on Blood test - Year-over-year growth 2022-2027 (%)
Exhibits 52: Chart on Urine test - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Urine test - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Urine test - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Urine test - Year-over-year growth 2022-2027 (%)
Exhibits 56: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 60: Market opportunity by Test ($ million)
Exhibits 61: Data Table on Market opportunity by Test ($ million)
Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 63: Chart on Market share by geography 2022-2027 (%)
Exhibits 64: Data Table on Market share by geography 2022-2027 (%)
Exhibits 65: Chart on Geographic comparison
Exhibits 66: Data Table on Geographic comparison
Exhibits 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits 103: Market opportunity by geography ($ million)
Exhibits 104: Data Tables on Market opportunity by geography ($ million)
Exhibits 105: Impact of drivers and challenges in 2022 and 2027
Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
Exhibits 107: Overview on factors of disruption
Exhibits 108: Impact of key risks on business
Exhibits 109: Vendors covered
Exhibits 110: Matrix on vendor position and classification
Exhibits 111: Abbott Laboratories - Overview
Exhibits 112: Abbott Laboratories - Business segments
Exhibits 113: Abbott Laboratories - Key news
Exhibits 114: Abbott Laboratories - Key offerings
Exhibits 115: Abbott Laboratories - Segment focus
Exhibits 116: ACON Laboratories Inc. - Overview
Exhibits 117: ACON Laboratories Inc. - Product/Service
Exhibits 118: ACON Laboratories Inc. - Key offerings
Exhibits 119: Bio Rad Laboratories Inc. - Overview
Exhibits 120: Bio Rad Laboratories Inc. - Business segments
Exhibits 121: Bio Rad Laboratories Inc. - Key news
Exhibits 122: Bio Rad Laboratories Inc. - Key offerings
Exhibits 123: Bio Rad Laboratories Inc. - Segment focus
Exhibits 124: BioCheck Inc. - Overview
Exhibits 125: BioCheck Inc. - Product/Service
Exhibits 126: BioCheck Inc. - Key offerings
Exhibits 127: bioMerieux SA - Overview
Exhibits 128: bioMerieux SA - Product/Service
Exhibits 129: bioMerieux SA - Key offerings
Exhibits 130: Biora Therapeutics Inc. - Overview
Exhibits 131: Biora Therapeutics Inc. - Product/Service
Exhibits 132: Biora Therapeutics Inc. - Key offerings
Exhibits 133: Cardinal Health Inc. - Overview
Exhibits 134: Cardinal Health Inc. - Business segments
Exhibits 135: Cardinal Health Inc. - Key news
Exhibits 136: Cardinal Health Inc. - Key offerings
Exhibits 137: Cardinal Health Inc. - Segment focus
Exhibits 138: Diabetomics Inc. - Overview
Exhibits 139: Diabetomics Inc. - Product/Service
Exhibits 140: Diabetomics Inc. - Key offerings
Exhibits 141: F. Hoffmann La Roche Ltd. - Overview
Exhibits 142: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 143: F. Hoffmann La Roche Ltd. - Key news
Exhibits 144: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 145: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 146: MedGyn Products Inc. - Overview
Exhibits 147: MedGyn Products Inc. - Product/Service
Exhibits 148: MedGyn Products Inc. - Key offerings
Exhibits 149: Metabolomic Diagnostics - Overview
Exhibits 150: Metabolomic Diagnostics - Product/Service
Exhibits 151: Metabolomic Diagnostics - Key offerings
Exhibits 152: Perkin Elmer Inc. - Overview
Exhibits 153: Perkin Elmer Inc. - Business segments
Exhibits 154: Perkin Elmer Inc. - Key news
Exhibits 155: Perkin Elmer Inc. - Key offerings
Exhibits 156: Perkin Elmer Inc. - Segment focus
Exhibits 157: Sera Prognostics Inc. - Overview
Exhibits 158: Sera Prognostics Inc. - Product/Service
Exhibits 159: Sera Prognostics Inc. - Key offerings
Exhibits 160: Siemens AG - Overview
Exhibits 161: Siemens AG - Business segments
Exhibits 162: Siemens AG - Key news
Exhibits 163: Siemens AG - Key offerings
Exhibits 164: Siemens AG - Segment focus
Exhibits 165: Thermo Fisher Scientific Inc. - Overview
Exhibits 166: Thermo Fisher Scientific Inc. - Business segments
Exhibits 167: Thermo Fisher Scientific Inc. - Key news
Exhibits 168: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 169: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 170: Inclusions checklist
Exhibits 171: Exclusions checklist
Exhibits 172: Currency conversion rates for US$
Exhibits 173: Research methodology
Exhibits 174: Validation techniques employed for market sizing
Exhibits 175: Information sources
Exhibits 176: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global preeclampsia laboratory testing market: Abbott Laboratories, ACON Laboratories Inc., Bio Rad Laboratories Inc., BioCheck Inc., bioMerieux SA, Biora Therapeutics Inc., Cardinal Health Inc., Diabetomics Inc., F. Hoffmann La Roche Ltd., GestVision Inc., Lifeassay Diagnostics Pty Ltd., MedGyn Products Inc., Metabolomic Diagnostics, MOMM Diagnostics, Perkin Elmer Inc., Quidel Corp., Sera Prognostics Inc., Siemens AG, Thermo Fisher Scientific Inc., and Avecon Healthcare Pvt. Ltd.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the growing need for companion diagnostics.'

According to the report, one of the major drivers for this market is the market expansion in emerging economies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • ACON Laboratories Inc.
  • Bio Rad Laboratories Inc.
  • BioCheck Inc.
  • bioMerieux SA
  • Biora Therapeutics Inc.
  • Cardinal Health Inc.
  • Diabetomics Inc.
  • F. Hoffmann La Roche Ltd.
  • GestVision Inc.
  • Lifeassay Diagnostics Pty Ltd.
  • MedGyn Products Inc.
  • Metabolomic Diagnostics
  • MOMM Diagnostics
  • Perkin Elmer Inc.
  • Quidel Corp.
  • Sera Prognostics Inc.
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Avecon Healthcare Pvt. Ltd.